Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1087 | Pterocarpus santalinus | Species | Fabaceae | Eukaryota | Heartwood | India |
PMID[21488654] |
|
NPO20876 | Arnica longifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO23269 | Spodoptera exigua | Species | Noctuidae | Eukaryota | UNPD* | |||
NPO26331 | Plumbago auriculata | Species | Plumbaginaceae | Eukaryota | UNPD* | |||
NPO17889 | Clerodendrum indicum | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO20888 | Paraderris canarensis | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO23821 | Rubus rigidus | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO6173 | Senegalia caesia | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO22848 | Kaempferia galanga | Species | Zingiberaceae | Eukaryota | UNPD* | |||
NPO1087 | Pterocarpus santalinus | Species | Fabaceae | Eukaryota | heartwood |
PMID[21488654] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 17.1 | ug/ml | 21488654 |
NPT1031 | Cell Line | Ca9-22 | Homo sapiens | IC50 | > | 17.1 | ug/ml | 21488654 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 17.1 | ug/ml | 21488654 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 17.1 | ug/ml | 21488654 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 17.1 | ug/ml | 21488654 |
NPT2 | Others | Unspecified | IC50 | > | 17.1 | ug/ml | 21488654 | |
NPT2 | Others | Unspecified | IC50 | = | 3.18 | ug/ml | 21488654 | |
NPT2 | Others | Unspecified | Inhibition | = | -1.53 | % | 21488654 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC7439 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC34245 |
1.0 | High Similarity | NPC91492 |
1.0 | High Similarity | NPC256555 |
1.0 | High Similarity | NPC110067 |
0.963 | High Similarity | NPC38874 |
0.963 | High Similarity | NPC474886 |
0.9504 | High Similarity | NPC139839 |
0.9485 | High Similarity | NPC52086 |
0.9485 | High Similarity | NPC95162 |
0.9485 | High Similarity | NPC20511 |
0.9485 | High Similarity | NPC139548 |
0.9485 | High Similarity | NPC148835 |
0.9485 | High Similarity | NPC76336 |
0.9481 | High Similarity | NPC234865 |
0.9437 | High Similarity | NPC30688 |
0.9437 | High Similarity | NPC176903 |
0.9433 | High Similarity | NPC231149 |
0.9416 | High Similarity | NPC13067 |
0.9412 | High Similarity | NPC286843 |
0.9412 | High Similarity | NPC82271 |
0.9412 | High Similarity | NPC126682 |
0.9371 | High Similarity | NPC21184 |
0.9371 | High Similarity | NPC205727 |
0.9371 | High Similarity | NPC294522 |
0.9371 | High Similarity | NPC120426 |
0.9333 | High Similarity | NPC277021 |
0.9296 | High Similarity | NPC476347 |
0.9286 | High Similarity | NPC236419 |
0.9265 | High Similarity | NPC106215 |
0.9265 | High Similarity | NPC92830 |
0.9241 | High Similarity | NPC264875 |
0.9241 | High Similarity | NPC120774 |
0.9241 | High Similarity | NPC163598 |
0.9231 | High Similarity | NPC476348 |
0.9231 | High Similarity | NPC187398 |
0.9231 | High Similarity | NPC48366 |
0.922 | High Similarity | NPC185127 |
0.9191 | High Similarity | NPC26673 |
0.9161 | High Similarity | NPC275125 |
0.9161 | High Similarity | NPC97937 |
0.9161 | High Similarity | NPC15577 |
0.9161 | High Similarity | NPC178129 |
0.9161 | High Similarity | NPC170239 |
0.9149 | High Similarity | NPC230157 |
0.9149 | High Similarity | NPC6568 |
0.9137 | High Similarity | NPC164148 |
0.9137 | High Similarity | NPC43500 |
0.9124 | High Similarity | NPC474600 |
0.9124 | High Similarity | NPC111635 |
0.9118 | High Similarity | NPC202762 |
0.9118 | High Similarity | NPC137949 |
0.9118 | High Similarity | NPC86655 |
0.9065 | High Similarity | NPC102904 |
0.9065 | High Similarity | NPC176051 |
0.9065 | High Similarity | NPC103976 |
0.9065 | High Similarity | NPC276490 |
0.9065 | High Similarity | NPC107551 |
0.9065 | High Similarity | NPC474282 |
0.9065 | High Similarity | NPC326797 |
0.9051 | High Similarity | NPC229442 |
0.9051 | High Similarity | NPC168059 |
0.9051 | High Similarity | NPC474810 |
0.9048 | High Similarity | NPC150442 |
0.9044 | High Similarity | NPC73738 |
0.9034 | High Similarity | NPC113790 |
0.9021 | High Similarity | NPC125617 |
0.9007 | High Similarity | NPC300611 |
0.9 | High Similarity | NPC25966 |
0.9 | High Similarity | NPC245207 |
0.9 | High Similarity | NPC319647 |
0.9 | High Similarity | NPC127218 |
0.8993 | High Similarity | NPC472334 |
0.8993 | High Similarity | NPC472336 |
0.8986 | High Similarity | NPC8712 |
0.898 | High Similarity | NPC53587 |
0.898 | High Similarity | NPC176186 |
0.898 | High Similarity | NPC169404 |
0.8978 | High Similarity | NPC245120 |
0.8978 | High Similarity | NPC319969 |
0.8978 | High Similarity | NPC127624 |
0.8971 | High Similarity | NPC299221 |
0.8971 | High Similarity | NPC234488 |
0.8971 | High Similarity | NPC311680 |
0.8971 | High Similarity | NPC51840 |
0.8971 | High Similarity | NPC214860 |
0.8971 | High Similarity | NPC91291 |
0.8971 | High Similarity | NPC244799 |
0.8971 | High Similarity | NPC240722 |
0.8958 | High Similarity | NPC268515 |
0.8958 | High Similarity | NPC287275 |
0.8958 | High Similarity | NPC205361 |
0.8958 | High Similarity | NPC40222 |
0.8951 | High Similarity | NPC471763 |
0.8944 | High Similarity | NPC469564 |
0.8944 | High Similarity | NPC472335 |
0.8944 | High Similarity | NPC472332 |
0.8929 | High Similarity | NPC105493 |
0.8929 | High Similarity | NPC476171 |
0.8921 | High Similarity | NPC112246 |
0.8921 | High Similarity | NPC472337 |
0.8921 | High Similarity | NPC470356 |
0.8921 | High Similarity | NPC195022 |
0.8921 | High Similarity | NPC252095 |
0.8921 | High Similarity | NPC474206 |
0.8921 | High Similarity | NPC112939 |
0.8921 | High Similarity | NPC94750 |
0.8921 | High Similarity | NPC121812 |
0.8913 | High Similarity | NPC241341 |
0.8913 | High Similarity | NPC36437 |
0.8913 | High Similarity | NPC233018 |
0.8912 | High Similarity | NPC213197 |
0.8905 | High Similarity | NPC142530 |
0.8905 | High Similarity | NPC147317 |
0.8897 | High Similarity | NPC27239 |
0.8897 | High Similarity | NPC10225 |
0.8897 | High Similarity | NPC123127 |
0.8897 | High Similarity | NPC58164 |
0.8897 | High Similarity | NPC45824 |
0.8881 | High Similarity | NPC138212 |
0.8873 | High Similarity | NPC471389 |
0.8865 | High Similarity | NPC270256 |
0.8859 | High Similarity | NPC7178 |
0.8859 | High Similarity | NPC62903 |
0.8857 | High Similarity | NPC162659 |
0.8857 | High Similarity | NPC227503 |
0.8857 | High Similarity | NPC248727 |
0.8857 | High Similarity | NPC474639 |
0.8857 | High Similarity | NPC173660 |
0.8857 | High Similarity | NPC16435 |
0.8857 | High Similarity | NPC265433 |
0.8857 | High Similarity | NPC230734 |
0.8857 | High Similarity | NPC167517 |
0.8857 | High Similarity | NPC306441 |
0.8857 | High Similarity | NPC270456 |
0.8849 | High Similarity | NPC317380 |
0.8849 | High Similarity | NPC473054 |
0.8849 | High Similarity | NPC309953 |
0.8841 | High Similarity | NPC6451 |
0.8841 | High Similarity | NPC137669 |
0.8841 | High Similarity | NPC474635 |
0.8828 | High Similarity | NPC475896 |
0.8824 | High Similarity | NPC266691 |
0.8824 | High Similarity | NPC46274 |
0.8824 | High Similarity | NPC226331 |
0.8811 | High Similarity | NPC107161 |
0.8803 | High Similarity | NPC160283 |
0.8803 | High Similarity | NPC259519 |
0.8803 | High Similarity | NPC254759 |
0.88 | High Similarity | NPC155015 |
0.88 | High Similarity | NPC142479 |
0.8794 | High Similarity | NPC126206 |
0.8794 | High Similarity | NPC211549 |
0.8786 | High Similarity | NPC234333 |
0.8786 | High Similarity | NPC201357 |
0.8786 | High Similarity | NPC224941 |
0.8786 | High Similarity | NPC472521 |
0.8786 | High Similarity | NPC311430 |
0.8786 | High Similarity | NPC47398 |
0.8786 | High Similarity | NPC134968 |
0.8786 | High Similarity | NPC281521 |
0.8786 | High Similarity | NPC255147 |
0.8786 | High Similarity | NPC61946 |
0.8786 | High Similarity | NPC260898 |
0.8786 | High Similarity | NPC151224 |
0.8777 | High Similarity | NPC472522 |
0.8777 | High Similarity | NPC11060 |
0.8777 | High Similarity | NPC36661 |
0.8777 | High Similarity | NPC475840 |
0.8776 | High Similarity | NPC206264 |
0.8776 | High Similarity | NPC212670 |
0.8776 | High Similarity | NPC313334 |
0.8768 | High Similarity | NPC474356 |
0.8768 | High Similarity | NPC232275 |
0.8768 | High Similarity | NPC12275 |
0.8768 | High Similarity | NPC45715 |
0.8766 | High Similarity | NPC234004 |
0.8759 | High Similarity | NPC292256 |
0.875 | High Similarity | NPC324112 |
0.875 | High Similarity | NPC236791 |
0.875 | High Similarity | NPC74817 |
0.875 | High Similarity | NPC250432 |
0.875 | High Similarity | NPC246620 |
0.875 | High Similarity | NPC5447 |
0.875 | High Similarity | NPC82679 |
0.875 | High Similarity | NPC216836 |
0.875 | High Similarity | NPC124452 |
0.875 | High Similarity | NPC293054 |
0.875 | High Similarity | NPC169474 |
0.875 | High Similarity | NPC210355 |
0.875 | High Similarity | NPC282000 |
0.875 | High Similarity | NPC159968 |
0.8741 | High Similarity | NPC168259 |
0.8741 | High Similarity | NPC247291 |
0.8741 | High Similarity | NPC472520 |
0.8741 | High Similarity | NPC83375 |
0.8741 | High Similarity | NPC279851 |
0.8741 | High Similarity | NPC224876 |
0.8733 | High Similarity | NPC268484 |
0.8732 | High Similarity | NPC260741 |
0.8732 | High Similarity | NPC70682 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC7439 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8824 | High Similarity | NPD1529 | Clinical (unspecified phase) |
0.8776 | High Similarity | NPD1653 | Approved |
0.875 | High Similarity | NPD1530 | Clinical (unspecified phase) |
0.8705 | High Similarity | NPD1613 | Approved |
0.8705 | High Similarity | NPD1612 | Clinical (unspecified phase) |
0.8609 | High Similarity | NPD2801 | Approved |
0.8489 | Intermediate Similarity | NPD3027 | Phase 3 |
0.8444 | Intermediate Similarity | NPD422 | Phase 1 |
0.8421 | Intermediate Similarity | NPD1934 | Approved |
0.8258 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8255 | Intermediate Similarity | NPD1511 | Approved |
0.8194 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8146 | Intermediate Similarity | NPD1512 | Approved |
0.8129 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8129 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8086 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8026 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.8015 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8 | Intermediate Similarity | NPD7549 | Discontinued |
0.8 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7933 | Intermediate Similarity | NPD3750 | Approved |
0.7914 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7914 | Intermediate Similarity | NPD3818 | Discontinued |
0.7911 | Intermediate Similarity | NPD3882 | Suspended |
0.7902 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7901 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7901 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7901 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7877 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7877 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7866 | Intermediate Similarity | NPD7054 | Approved |
0.7818 | Intermediate Similarity | NPD7472 | Approved |
0.7818 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7812 | Intermediate Similarity | NPD6234 | Discontinued |
0.7808 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7801 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7793 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7793 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD6232 | Discontinued |
0.7746 | Intermediate Similarity | NPD3225 | Approved |
0.7736 | Intermediate Similarity | NPD5402 | Approved |
0.7733 | Intermediate Similarity | NPD7266 | Discontinued |
0.7727 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7716 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7714 | Intermediate Similarity | NPD3496 | Discontinued |
0.7708 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7708 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7692 | Intermediate Similarity | NPD2797 | Approved |
0.7667 | Intermediate Similarity | NPD2935 | Discontinued |
0.7665 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7665 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.764 | Intermediate Similarity | NPD7075 | Discontinued |
0.7636 | Intermediate Similarity | NPD7473 | Discontinued |
0.7635 | Intermediate Similarity | NPD230 | Phase 1 |
0.7635 | Intermediate Similarity | NPD447 | Suspended |
0.763 | Intermediate Similarity | NPD228 | Approved |
0.7622 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD7251 | Discontinued |
0.761 | Intermediate Similarity | NPD37 | Approved |
0.7603 | Intermediate Similarity | NPD4625 | Phase 3 |
0.76 | Intermediate Similarity | NPD3748 | Approved |
0.7582 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD4965 | Approved |
0.7578 | Intermediate Similarity | NPD4966 | Approved |
0.7578 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7574 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7566 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7552 | Intermediate Similarity | NPD4749 | Approved |
0.7552 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7552 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7551 | Intermediate Similarity | NPD3268 | Approved |
0.7548 | Intermediate Similarity | NPD6799 | Approved |
0.7546 | Intermediate Similarity | NPD5494 | Approved |
0.7534 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD6190 | Approved |
0.7531 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD4340 | Discontinued |
0.7516 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6233 | Phase 2 |
0.75 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6801 | Discontinued |
0.7485 | Intermediate Similarity | NPD919 | Approved |
0.7485 | Intermediate Similarity | NPD7228 | Approved |
0.7484 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7483 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7483 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7483 | Intermediate Similarity | NPD7095 | Approved |
0.7453 | Intermediate Similarity | NPD7819 | Suspended |
0.7451 | Intermediate Similarity | NPD1549 | Phase 2 |
0.745 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7445 | Intermediate Similarity | NPD5535 | Approved |
0.7434 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7432 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7432 | Intermediate Similarity | NPD6798 | Discontinued |
0.7413 | Intermediate Similarity | NPD1611 | Approved |
0.741 | Intermediate Similarity | NPD6671 | Approved |
0.7405 | Intermediate Similarity | NPD5403 | Approved |
0.7391 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7389 | Intermediate Similarity | NPD5401 | Approved |
0.7375 | Intermediate Similarity | NPD6599 | Discontinued |
0.7368 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7362 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7355 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7333 | Intermediate Similarity | NPD1240 | Approved |
0.7329 | Intermediate Similarity | NPD3266 | Approved |
0.7329 | Intermediate Similarity | NPD3267 | Approved |
0.7329 | Intermediate Similarity | NPD7411 | Suspended |
0.7325 | Intermediate Similarity | NPD4357 | Discontinued |
0.732 | Intermediate Similarity | NPD2796 | Approved |
0.7315 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD6559 | Discontinued |
0.7305 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7292 | Intermediate Similarity | NPD1535 | Discovery |
0.729 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7289 | Intermediate Similarity | NPD1247 | Approved |
0.7285 | Intermediate Similarity | NPD1933 | Approved |
0.7285 | Intermediate Similarity | NPD6355 | Discontinued |
0.7278 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4626 | Approved |
0.7255 | Intermediate Similarity | NPD7033 | Discontinued |
0.7241 | Intermediate Similarity | NPD1608 | Approved |
0.7241 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7241 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD1607 | Approved |
0.7235 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7229 | Intermediate Similarity | NPD5677 | Discontinued |
0.7222 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD943 | Approved |
0.7216 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD3749 | Approved |
0.7211 | Intermediate Similarity | NPD1203 | Approved |
0.7208 | Intermediate Similarity | NPD6100 | Approved |
0.7208 | Intermediate Similarity | NPD6099 | Approved |
0.7186 | Intermediate Similarity | NPD8127 | Discontinued |
0.7179 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD6674 | Discontinued |
0.7172 | Intermediate Similarity | NPD1091 | Approved |
0.717 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7161 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7161 | Intermediate Similarity | NPD5763 | Approved |
0.7161 | Intermediate Similarity | NPD5762 | Approved |
0.716 | Intermediate Similarity | NPD4678 | Approved |
0.716 | Intermediate Similarity | NPD4675 | Approved |
0.7143 | Intermediate Similarity | NPD3686 | Approved |
0.7143 | Intermediate Similarity | NPD3687 | Approved |
0.7134 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7132 | Intermediate Similarity | NPD968 | Approved |
0.7107 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7107 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7105 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7101 | Intermediate Similarity | NPD3022 | Approved |
0.7101 | Intermediate Similarity | NPD3021 | Approved |
0.7099 | Intermediate Similarity | NPD3226 | Approved |
0.7097 | Intermediate Similarity | NPD6032 | Approved |
0.7097 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7091 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD4288 | Approved |
0.7089 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD2313 | Discontinued |
0.7083 | Intermediate Similarity | NPD5691 | Approved |
0.7081 | Intermediate Similarity | NPD920 | Approved |
0.7076 | Intermediate Similarity | NPD3751 | Discontinued |
0.707 | Intermediate Similarity | NPD1243 | Approved |
0.7063 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD2533 | Approved |
0.7063 | Intermediate Similarity | NPD2532 | Approved |
0.7063 | Intermediate Similarity | NPD2534 | Approved |
0.7059 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD9697 | Approved |
0.7055 | Intermediate Similarity | NPD3705 | Approved |
0.7041 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7034 | Intermediate Similarity | NPD17 | Approved |
0.7034 | Intermediate Similarity | NPD1778 | Approved |
0.7029 | Intermediate Similarity | NPD2684 | Approved |
0.7027 | Intermediate Similarity | NPD8651 | Approved |
0.7011 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7011 | Intermediate Similarity | NPD7240 | Approved |
0.7007 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7007 | Intermediate Similarity | NPD9717 | Approved |
0.7006 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD2424 | Discontinued |
0.7006 | Intermediate Similarity | NPD6971 | Discontinued |
0.7 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7 | Intermediate Similarity | NPD9494 | Approved |
0.7 | Intermediate Similarity | NPD5242 | Approved |
0.6994 | Remote Similarity | NPD4005 | Discontinued |
0.6994 | Remote Similarity | NPD8158 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD3620 | Phase 2 |
0.6993 | Remote Similarity | NPD3619 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD4140 | Approved |
0.6989 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6989 | Remote Similarity | NPD8054 | Approved |
PubChem CID   | 15560441 |
ChEMBL   | CHEMBL1801610 |
ZINC   |
Molecular Weight:   | 314.08 |
ALogP:   | -0.9498 |
MLogP:   | 2.67 |
XLogP:   | 1.645 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 85.22 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 23 |